[96a5a0]: / output / allTrials / identified / NCT01691976_identified.json

Download this file

204 lines (204 with data), 8.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
{
"info": {
"nct_id": "NCT01691976",
"official_title": "Mild Cognitive Impairment in Men Following Androgen Deprivation Therapy for Prostate Cancer: a Longitudinal fMRI and qEEG Pilot Study.",
"inclusion_criteria": "* Male patients between the ages 50 to 90 years beginning ADT with LHRHa or PATCH participants randomised to either LHRHa or transdermal oestrogen for either newly diagnosed advanced prostate cancer or previously treated with radical radiotherapy or surgery and now having a rising prostate specific antigen will be included in the study.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 50 Years\nMust have maximum age of 90 Years",
"exclusion_criteria": "* Patients with a known history of dementia will be excluded as well as those patients who have received any prior hormone therapy for localised prostate cancer.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Male patients between the ages 50 to 90 years beginning ADT with LHRHa or PATCH participants randomised to either LHRHa or transdermal oestrogen for either newly diagnosed advanced prostate cancer or previously treated with radical radiotherapy or surgery and now having a rising prostate specific antigen will be included in the study.",
"criterions": [
{
"exact_snippets": "Male patients",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "male"
}
]
},
{
"exact_snippets": "between the ages 50 to 90 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 50,
"unit": "years"
},
{
"operator": "<=",
"value": 90,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "beginning ADT",
"criterion": "ADT status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "beginning"
}
]
},
{
"exact_snippets": "LHRHa or PATCH participants randomised to either LHRHa or transdermal oestrogen",
"criterion": "treatment type",
"requirements": [
{
"requirement_type": "options",
"expected_value": [
"LHRHa",
"transdermal oestrogen"
]
}
]
},
{
"exact_snippets": "newly diagnosed advanced prostate cancer",
"criterion": "prostate cancer diagnosis",
"requirements": [
{
"requirement_type": "status",
"expected_value": "newly diagnosed advanced"
}
]
},
{
"exact_snippets": "previously treated with radical radiotherapy or surgery",
"criterion": "previous treatment",
"requirements": [
{
"requirement_type": "options",
"expected_value": [
"radical radiotherapy",
"surgery"
]
}
]
},
{
"exact_snippets": "now having a rising prostate specific antigen",
"criterion": "prostate specific antigen status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "rising"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 50 Years",
"criterions": [
{
"exact_snippets": "minimum age of 50 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 90 Years",
"criterions": [
{
"exact_snippets": "maximum age of 90 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 90,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients with a known history of dementia will be excluded as well as those patients who have received any prior hormone therapy for localised prostate cancer.",
"criterions": [
{
"exact_snippets": "known history of dementia",
"criterion": "dementia",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "received any prior hormone therapy for localised prostate cancer",
"criterion": "prior hormone therapy for localised prostate cancer",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}